AVEO Discovers Potential Cancer Breakthrough

AVEO Pharmaceuticals Inc. (NASDAQ: AVEO) was up $0.75 (9.14%) this morning to $8.96 following reports that by introducing an experimental drug during chemotherapy the company had succeeded to wipe out brain cancer cells in mice.  This news provides hope for a new treatment for the disease in humans, and testing in humans has already begun.

AVEO Pharmaceuticals Inc. is a biopharma company that specializes in cancer therapeutics.  Up until 2005 the company was known as GenPath Pharmaceuticals.

-Michael B. Sauter

Comments

BioHealth Investor RSS Feed

• 

• Recent Posts

  • Shouldn’t VIVUS Raise Capital Now? (VVUS)
  • Can Human Genome Really Double Its Stock Price? (HGSI)
  • Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
  • Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
  • Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)

• Archives

  • February 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011

• Categories

  • Acquisitions
  • alzheimer's
  • analyst calls
  • Anemia
  • Atherosclerosis
  • blogfile
  • Cancer
  • Cardiac
  • Contraceptives
  • daily
  • dendreon
  • Depression
  • Devices
  • Diabetes
  • Diagnostics
  • Epilepsy
  • erectile dysfunction
  • fda
  • fibromyalgia
  • Financial
  • flu
  • General
  • generic drugs
  • genomics
  • Heart
  • Hepatitis C
  • HIV
  • Infections
  • IPO
  • Lung
  • Lupus
  • M&A
  • Medicare
  • Meningitis
  • merck
  • mesothelioma
  • MRSA
  • multiple sclerosis
  • obesity
  • Options
  • osteoporosis
  • Pain
  • papilloma virus
  • politics
  • psoriasis
  • R&D
  • Research
  • rheumatoid arthritis
  • Rumor
  • Secondary Offering
  • shingles
  • Sleep Disorder
  • stem cells
  • targacept
  • Uncategorized
  • vaccine

• Latest from 247Wallst.com

  • Farm, Construction Machinery Remains Solid
  • GE Finally Starts Getting GE Capital Dividends Again, Plus $4.5 Billion Special Dividend
  • SINA Rides China Social Media & Microblogging Growth Bandwagon
  • April Housing Starts Kept Lower By Northeast & West Regions
  • Top Analyst Upgrades & Downgrades

• Latest from VSInvestor

  • Huge Volume Spike in LED Stocks: It Looks Real This Time (CREE, VECO, AIXG)
  • Chart Damage in Apple on Above-Average Volume (AAPL)
  • Sizing Up Express-1 (XPO, URI)
  • Odds-Making: Is Brocade Really Bait For Dell? (BRCD, DELL, CSCO, HPQ)
  • Volume Spike Analysis in Broadwind Energy (BWEN)

• Biotech Resources

  • BIO.com
  • BIO.org
  • BioSpace
  • Centient Biotech Investor
  • Council For Biotech Info
  • EOFHR
  • Nature Biotechnology
  • TR Biotech
  • Yahoo! Finance: Healthcare

• More on Money & Finance

  • AMT
  • Banking
  • Black Friday Deals
  • Credit Cards
  • Credit Reports
  • DailyFinance
  • DJIA
  • Earnings
  • Identity Theft
  • Income Tax Basics
  • Insurance
  • Loans
  • Luxist
  • Market News
  • Money
  • Mortgages
  • Online Tax Filing
  • Recession
  • Retirement
  • Small Business
  • Stock Charts
  • Stock Quotes
  • Stock Ticker
  • Tax Credit
  • Tax Deduction
  • Taxes
  • Walletpop